Navigation Links
Springer to publish Reproductive Medicine and Biology
Date:2/18/2009

Reproductive Medicine and Biology publishes original research articles that report new findings and concepts in all aspects of reproductive phenomena in all kinds of mammals. The journal contributes to progress in research in many fields, including andrology, endocrinology, oncology, immunology, genetics, surgery and ethics and social issues. The various subjects are examined at the biological, biochemical, biophysical, molecular biological, analytically morphological and clinical levels. Reports on techniques are also considered, providing a platform for the publication and the exchange of ideas among professionals from multidisciplinary fields.

Editor-in-chief Professor Hiroshi Imai from Kyoto University in Japan is supported by an expert editorial board. Imai said, "Reproductive Medicine and Biology will continue to be active in publishing original and informative research articles that provide new insights in the field. I anticipate that as we begin our association with Springer, many excellent manuscripts from countries around the world will be submitted."

Dr. William F. Curtis, Executive Vice President, Clinical Medicine at Springer, said, "Springer welcomes the opportunity to publish Reproductive Medicine and Biology and to work closely with the three distinguished Japanese medical societies that sponsor the journal. We are proud to bring the excellent and timely research published in the journal to the international community via SpringerLink, thereby giving both authors and readers the benefit of state-of-the-art global communication."

Under Springer, Reproductive Medicine and Biology will make use of a manuscript tracking system that speeds publication of important articles in the field. Articles will be published in Online First in full text via SpringerLink. This system ensures immediate distribution of the electronic version of the article before it appears in print. Cross Reference
'/>"/>

Contact: Renate Bayaz
renate.bayaz@springer.com
49-622-148-78531
Springer
Source:Eurekalert

Page: 1 2

Related biology news :

1. Mycotoxin Research joins Springers life sciences journals program
2. Springer author and advisory board member wins LOreal UNESCO Women in Science Award
3. Springer expands its portfolio in plant sciences with Phytoparasitica
4. Springer and the Physiological Society of Japan sign publishing agreement
5. Springer looks ahead to the Future City
6. Springer partners with Botanical Society of Korea
7. Springer to publish Fisheries Science as of 2009
8. Springer launches Food Security
9. International Journal of Social Robotics debuts at Springer
10. Springer bee expert Juergen Tautz wins prize for public communication
11. Journal of Nutrition, Health and Aging to be published by Springer

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)...y of Pittsburgh team overcame a major hurdle plagu... that could lead to more efficient catalysts used ...xic. The researchers reported Nov. 29 in Nature M...ure stability in metallic nanoparticles, the vaunt...bility to extreme heat. , Gtz Veser, an associat...
(Date:11/30/2009)...ournal of Experimental Biology are pleased to ann...e la Recherche Scientifique (CNRS) in the Universi...ear,s JEB Outstanding Paper Prize. ,The prize is...ent and is intended to encourage young scientists,...and adds that ,we truly appreciate when authors su...
(Date:11/30/2009)...er early bird registration rates and register onli...010 at http://www.iofwco-ecceo10.org/ , WHAT:...ational Osteoporosis Foundation (IOF) and the Euro...Osteoporosis and Osteoarthritis (ESCEO). More than...cted to attend. The exciting scientific programme ...
Breaking Biology News(10 mins):First metallic nanoparticles resistant to extreme heat 2French scientist wins the Journal of Experimental Biology Outstanding Paper Prize 2009 2French scientist wins the Journal of Experimental Biology Outstanding Paper Prize 2009 3French scientist wins the Journal of Experimental Biology Outstanding Paper Prize 2009 4Perrigo Company To Present at the Sidoti Emerging Growth Conference 6399 1How to execute dietary management in eating disorder patients 61699 1How to execute dietary management in eating disorder patients 61699 2TGen Drug Development establishes European footprint 10804 1TGen Drug Development establishes European footprint 10804 2
... identified a gene ?and the molecular function of ...ue to further understanding obesity and may point ..., The scientists found that the human protein know... activity may be an important pharmaceutical targe...conditions that range from obesity to the loss of ...
...a risk for gastrointestinal illness, most visitors...d prevent infection. In addition, some engage in b...on according to several studies being presented th...g Infectious Diseases. , Researchers from the CDC... of an outbreak of , E. coli O157:H7 associated ...
...ail of scents when they are attacked by certain pe...otton leaf worm. , Parasitic wasps use these plant...eir eggs on it, so that their offspring can feed o...es and the plant is relieved from its attacker. In... activated to attract the parasitic wasps. This ge...
Other Biology News:Rutgers researchers find fat gene 2Common practices at petting zoos put visitors at risk 2New possibilities to fight pests with biological means 2
(Date:11/30/2009)...30 Acuo Technologies, developers o...re, data migration tools and services, today annou... for a new Vendor Neutral Archive (VNA), providing... network of hospitals, clinics and affiliates. ,...hnologies DICOM Services Grid(TM) Software. The A...
(Date:11/30/2009)... Novavax, Inc. (Nasdaq: ... today that the company will be presenting at the ...r 2, 2009 at 12:30 pm local time at The New York P... of the company,s business strategy, research and ...ink to the live audio only presentation can be acc...
(Date:11/30/2009)...30 Biopharmaceutical company Kiadi...ave been enrolled in its,multinational registratio...ned to show reduction in transplant related mortal...tem cell transplantation with a mismatched,(haplo-... for an allogeneic,stem cell transplantation but w...
(Date:11/30/2009)...nd LOS ANGELES, Nov. 30 /PRNewswire-Asia-FirstCall...etin Board: CYXN; ,China Yongxin,Pharmaceuticals, ...utor and,retailer of pharmaceuticals in Northeaste...tion for distribution of medicines on the Essentia...ently formalized the nation,s Essential Drug,List ...
Breaking Biology Technology:Acuo Technologies Announces Contract for Vendor Neutral Archive With Allina Hospitals and Clinics 2Acuo Technologies Announces Contract for Vendor Neutral Archive With Allina Hospitals and Clinics 3NOVAVAX to Present at the Piper Jaffray 21st Annual Health Care Conference 2Kiadis Pharma Announces Enrollment of First Patients in a Multinational Registration Study for ATIR(TM) 2China Yongxin Pharmaceuticals Inc. to Distribute Medicines on the Essential Drug List 2China Yongxin Pharmaceuticals Inc. to Distribute Medicines on the Essential Drug List 3
...AIN VIEW, Calif., March 12 Alexza,Pharmaceuticals...ll release,results for its fiscal year ended Decem...the close of the U.S. financial markets. The Compa...s the financial results and other,clinical develop...ay. A,replay of the call will be available for two...
...ded Agreement Accelerates Expected Timing of Final...le Powering of Interim and Final Results-, -Dendre...2008 at 11:00 AM ...daq: DNDN ) today announced that the U.S. Food an...ed Special Protocol Assessment (SPA) for the,Phase...
...nds PDE10 Collaboration with Amgen- -Com...ONTVALE, N.J., March 12 Memory,Pharmaceuticals Co...ealigned,its operations, reallocated its resources...its PDE10 collaboration with Amgen. The Company wi...o partnered programs, its,nicotinic alpha-7 recept...
Other Biology Technology:Alexza to Announce 2007 Financial Results and Update Its Clinical Pipeline on Monday, March 17, 2008 2Alexza to Announce 2007 Financial Results and Update Its Clinical Pipeline on Monday, March 17, 2008 3FDA Agrees to Amend Dendreon's Special Protocol Assessment for Phase 3 IMPACT Study of PROVENGE 2FDA Agrees to Amend Dendreon's Special Protocol Assessment for Phase 3 IMPACT Study of PROVENGE 3FDA Agrees to Amend Dendreon's Special Protocol Assessment for Phase 3 IMPACT Study of PROVENGE 4Memory Pharmaceuticals Refocuses to Advance Development and Clinical Programs 2Memory Pharmaceuticals Refocuses to Advance Development and Clinical Programs 3Memory Pharmaceuticals Refocuses to Advance Development and Clinical Programs 4Memory Pharmaceuticals Refocuses to Advance Development and Clinical Programs 5
Fingerprinting II Informatix, optional matrix types module from Bio-Rad
... Lines ,High Quality, Functionally-Validated, Ion ...for having a critical role in nerve and muscle fun..., CNS and the heart. Drugs that modulate ion chann...uch as neuropathic pain, cardiac arrhythmia, hyper...
...are derived from frozen embedded tissue blocks, wh...edures to ensure the highest quality. Tissues of e...tioned at a thickness of 7 microns and mounted on ...ter) in comparison to core sections made using Tis...
...ations or for use in an automated line. The StatMa...fold provides greater ease, speed, convenience, an...StatMatic II can be connected to a range of bottle...ne-handed operation -- in a matter of seconds.,T...
Biology Products: